- Price is above Fair Value, showing premium demand versus the model.
TLRY
TOR
Week ended 07 Aug 2026
Weekly Investor Report
Tilray Brands, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
6.36 CAD
0.3%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -24.8% below the Trend Line and sits at 26.1% of its 52-week range. The latest completed week returned 0.3%, after a 2.1% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100.
Setup score
29
out of 100
Latest Close
6.36 CAD
7 Aug 2026
1W Return
0.3%
latest completed week
4W Return
2.1%
short-term follow-through
12W Return
-12.6%
quarterly tape
Trend Breadth
69.2%
36 of 52 weeks active
Volume Ratio
1.4x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 42.04% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.3%
Latest completed week; four-week move 2.1%.
Indicator stack
38/32
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 42.04%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
23 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -24.8% below the Trend Line and sits at 26.1% of its 52-week range. The latest completed week returned 0.3%, after a 2.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0512-week average 0.18
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership4/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.05Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 2.1% over four weeks, -12.6% over 12 weeks, and 606.7% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year36
Trend breadth69.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.12Latest activity-pressure read.
Pressure change29.7%Four-week change in activity pressure.
Leadership-17.65Latest relative-leadership reading.
RS change-41.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 May 2026
Field coverage 79%
Model confidence 79%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength69/100Blend of value, momentum, and quality. Underlying universe rank 32; rank 1 is best.
Value67/100Relative valuation strength. Underlying universe rank 34; rank 1 is best.
Quality3/100Profitability and accounting quality. Underlying universe rank 98; rank 1 is best.
Momentum100/100Medium-term price momentum. Underlying universe rank 1; rank 1 is best.
Growth71/100Revenue and earnings growth. Underlying universe rank 30; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 0.9x Market value relative to trailing revenue.
- EV / EBITDA
- 103.4x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -10.5% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 28.4% Gross profit retained from each unit of revenue.
- Operating margin
- -6.0% Operating profit retained from revenue.
- Free-cash-flow margin
- -11.2% Free cash flow generated from revenue.
- Return on invested capital
- -2.3% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 11.5% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 3/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- -20.1% Net share repurchases relative to market value.
- Shareholder yield
- -20.1% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 18.2x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 23 relevant articles.
5 positive · 16 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-70.5%Distance below the 52-week high.
13-week volatility6.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher10 of 2615 weeks finished lower.
Best week+15.5%Week of 31 Jul.
Worst week-9.9%Week of 20 Mar.
Latest week+0.3%Week of 7 Aug.
Shape of recent returns
Strong gains1
Modest gains9
Flat weeks1
Modest losses7
Sharp losses8
Recent vol6.0%13-week weekly-return volatility.
Base vol108.7%52-week weekly-return volatility.
Up/down split20/31Count of positive and negative weeks in the 52-week window.
Average skew51.7% / -7.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCA Healthcare
4-week rank17 / 46
Group average0.0%
Trend breadth34.8%
Trend34.8%active weekly trend signals
MD47.8%positive activity pressure
RS23.9%positive relative leadership
Four-week leaders
IndustryCA Drug Manufacturers - Specialty & Generic
4-week rank10 / 21
Group average3.7%
Trend breadth42.9%
Trend42.9%active weekly trend signals
MD47.6%positive activity pressure
RS23.8%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape27/100
Trend, activity pressure, participation, and risk combine to a 27/100 tape read.
Indicator analysis16/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 4/12.
Activity pressure 0.05; No reversal markers Next-Week ExpectancyNegative 42.04%Next-week expectancy is negative with a 42.04% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors57/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 96; Small Cap Core rank 68 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 23 relevant articles.
Tilray Brands (NASDAQ:TLRY) Trading Down 3.3% - What's Next? Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 6.36 CAD | 0.3% | 8.46 CAD | 3.72 CAD | -1.12 | -17.65 | 2.3M | Off |
| 31 Jul 2026 | 6.34 CAD | 15.5% | 8.67 CAD | 3.70 CAD | -1.43 | -14.11 | 3.5M | Off |
| 24 Jul 2026 | 5.49 CAD | -9.4% | 8.90 CAD | 3.68 CAD | -1.67 | -24.89 | 2.0M | Off |
| 17 Jul 2026 | 6.06 CAD | -2.7% | 9.18 CAD | 3.66 CAD | -1.62 | -15.90 | 2.1M | Off |
| 10 Jul 2026 | 6.23 CAD | -4.4% | 9.49 CAD | 3.64 CAD | -1.60 | -12.48 | 2.2M | Off |
| 3 Jul 2026 | 6.52 CAD | -0.6% | 9.84 CAD | 3.61 CAD | -1.58 | -6.95 | 258.7K | Off |
| 26 Jun 2026 | 6.56 CAD | -2.5% | 9.96 CAD | 3.59 CAD | -1.58 | -4.18 | 624.8K | Off |
| 19 Jun 2026 | 6.73 CAD | -3.3% | 9.78 CAD | 3.56 CAD | -1.52 | -0.02 | 78.4K | Off |
| 12 Jun 2026 | 6.96 CAD | 1.0% | 9.60 CAD | 3.53 CAD | -1.47 | 5.31 | 447.0K | Off |
| 5 Jun 2026 | 6.89 CAD | -9.1% | 9.42 CAD | 3.49 CAD | -1.38 | 7.79 | 987.8K | Off |
| 29 May 2026 | 7.58 CAD | 3.4% | 9.25 CAD | 3.46 CAD | -1.21 | 19.59 | 2.5M | Off |
| 22 May 2026 | 7.33 CAD | 0.7% | 9.06 CAD | 3.43 CAD | -1.07 | 19.10 | 1.9M | Off |
| 15 May 2026 | 7.28 CAD | -4.6% | 8.88 CAD | 3.40 CAD | -0.78 | 23.03 | 3.1M | Off |
| 8 May 2026 | 7.63 CAD | -8.9% | 8.71 CAD | 3.37 CAD | -0.62 | 30.74 | 3.2M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.